Antitumor agent for continuous intravenous administration containing cytidine derivative

摘要

A method for administering ECyd, which allows the treatment to be continued without developing the peripheral neurotoxicity of ECyd and provides a high therapeutic effect that reliably extends the survival period of the patient. An antitumor agent containing ECyd or a salt thereof, which is continuously intravenously administered to a cancer patient in an amount of 1.30 to 8.56 mg / m2 in terms of ECyd per administration over 2 to 336 hours. An antitumor agent characterized by that.